AbbVie (ABBV) Inventory (2012 - 2026)
AbbVie (ABBV) posted quarterly Inventory of $5.0 billion for Q1 2026, up 11.56% year-over-year from $4.5 billion in Q1 2025, and up 1.98% quarter-over-quarter from $5.0 billion in Q4 2025.
AbbVie (ABBV) Inventory (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Inventory for 15 consecutive years, with $5.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 11.56% year-over-year to $5.0 billion; the TTM figure through Mar 2026 stood at $5.0 billion (up 11.56% YoY), while the FY2025 annual figure was $5.0 billion, up 18.42% from the prior year.
- Inventory grew to $5.0 billion in Q1 2026 per ABBV's latest filing, from $5.0 billion in the prior quarter.
- Across five years, Inventory topped out at $5.0 billion in Q1 2026 and bottomed at $3.2 billion in Q3 2022.
- Historically, Inventory has averaged $4.2 billion across 5 years, with a median of $4.2 billion in 2024.
- Annual changes were most pronounced in 2022 — Inventory advanced 0.3% — and 2023, when it advanced 25.5%.
- AbbVie's Inventory stood at $3.6 billion in 2022, then rose by 14.53% to $4.1 billion in 2023, then increased by 2.0% to $4.2 billion in 2024, then advanced by 18.42% to $5.0 billion in 2025, then advanced by 1.98% to $5.0 billion in 2026.
- Business Quant data shows ABBV's Inventory at $5.0 billion in Q1 2026, $5.0 billion in Q4 2025, and $4.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.45 Bn | 631.70 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 469.14 Bn | 462.57 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 381.04 Bn | 373.90 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 301.58 Bn | 293.89 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 257.69 Bn | 252.79 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 236.91 Bn | 222.92 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 182.62 Bn | 179.44 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 161.28 Bn | 149.58 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 105.81 Bn | 101.64 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.98 Bn | 47.60 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.13 Bn |
| Mar 31, 2026 | 5.05 Bn |
| Dec 31, 2025 | 4.95 Bn |
| Sep 30, 2025 | 4.94 Bn |
| Jun 30, 2025 | 4.96 Bn |
| Mar 31, 2025 | 4.53 Bn |
| Dec 31, 2024 | 4.18 Bn |
| Sep 30, 2024 | 4.45 Bn |
| Jun 30, 2024 | 4.22 Bn |
| Mar 31, 2024 | 4.25 Bn |
| Dec 31, 2023 | 4.10 Bn |
| Sep 30, 2023 | 3.98 Bn |
| Jun 30, 2023 | 4.06 Bn |
| Mar 31, 2023 | 3.83 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Sep 30, 2022 | 3.17 Bn |
| Jun 30, 2022 | 3.40 Bn |
| Mar 31, 2022 | 3.48 Bn |
| Dec 31, 2021 | 3.13 Bn |
| Sep 30, 2021 | 3.09 Bn |